A clinical trial to compare the effect between triamcinolone with hyaluronidase injection and triamcinolone injection alone in keloid patients
Phase 4
Completed
- Conditions
- Health Condition 1: null- Keloid
- Registration Number
- CTRI/2018/07/014892
- Lead Sponsor
- Dr Prasanta Bhattacharya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Keloid lesion of size 2-5 cm
Exclusion Criteria
Patients having allergy to Hyaluronidase or Triamcinolone, Pregnant patients,Patients with ITP, patients with secondary infection in and around keloid.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in pigmentation,vascularity,pliability,scar heightTimepoint: 6,12,18,24 weeks
- Secondary Outcome Measures
Name Time Method Reduction in painTimepoint: 6,12,18,24 weeks;Reduction in pruritusTimepoint: 6,12,18,24 weeks